Excerpt: “These findings line up with results from smaller studies and clinical experience even though the study population “may not be representative of other regions of the country,” said Standaert, who wasn’t affiliated with the study.”
Excerpt: “I think these data are useful in a clinical setting in counseling patients about the effect of these diseases on their life, and what they should expect,” Standaert told MedPage Today. “On a broader sense, they are important for evaluating the public health impact of synucleinopathy and for planning clinical trials of disease-modifying agents.”